Medy-Tox
51
0
0
48
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
2.0%
1 terminated/withdrawn out of 51 trials
98.0%
+11.5% vs industry average
55%
28 trials in Phase 3/4
15%
7 of 48 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (51)
MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
Role: lead
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
Role: lead
MT10109L in the Treatment of Lateral Canthal Lines
Role: lead
MT10109L in the Treatment of Glabellar Lines
Role: lead
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
Role: lead
MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
Role: lead
Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
Role: lead
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)
Role: lead
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)
Role: lead
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
Role: lead
Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face
Role: lead
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
Role: lead
Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume
Role: lead
Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines
Role: lead
Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®
Role: lead
Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intrauterine
Role: lead
Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects
Role: lead
Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
Role: lead
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
Role: lead
The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines
Role: lead